Robert Hoffman, CFO & SVP, Finance at HERON THERAPEUTICS, INC. /DE/ (HRTX), sold 30,000 shares at $38.15 ($1.1M) on 2018-07-02, disclosed to the SEC on 2018-07-03.
Open-market sale of $1.1M HRTX by CFO & SVP, Finance. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.15 | 28,940 | $1.1M | 96.4% |
| 2 | $38.80 | 1,060 | $41K | 3.6% |
| Total | $38.17 avg | 30,000 | $1.1M | 100% |
| Filing → |
| ARNA | SELL | 2013-04-03 | $585K | — | Filing → |
| ARNA | SELL | 2012-10-02 | $416K | — | Filing → |
| ARNA | SELL | 2012-07-09 | $110K | — | Filing → |